Posttraumatic stress disorder comorbidity in patients undergoing ECT for major depressive disorder.

IF 1.5 4区医学 Q3 PSYCHIATRY

Annals of Clinical Psychiatry Pub Date : 2023-11-01 DOI:10.12788/acp.0115

Nagy A Youssef, Leon Brodsky, Rikinkumar S Patel

{"title":"Posttraumatic stress disorder comorbidity in patients undergoing ECT for major depressive disorder.","authors":"Nagy A Youssef, Leon Brodsky, Rikinkumar S Patel","doi":"10.12788/acp.0115","DOIUrl":null,"url":null,"abstract":"Background: Posttraumatic stress disorder (PTSD) is not recognized as an indication for electroconvulsive therapy (ECT). However, research indicates promise for this treatment modality. To elucidate the effects of ECT for treating PTSD, prospective research is needed. The first step in assessing the feasibility of such research is to determine if many patients being treated with ECT have comorbid PTSD. This study examined the PTSD comorbidity rates and compared demographic data among patients with major depressive disorder (MDD) who were treated with ECT vs patients with MDD who were not treated with ECT.Methods: Data from patients with MDD were obtained from the Nationwide Inpatient Sample.Results: Approximately 10% of patients undergoing ECT for MDD also had PTSD. The difference in comorbidity of PTSD in those treated with ECT vs those not treated with ECT was approximately 1%.Conclusions: Prospective naturalistic studies that examine the response of PTSD to ECT are feasible because a sizable number of patients with PTSD are receiving ECT.","PeriodicalId":50770,"journal":{"name":"Annals of Clinical Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Clinical Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12788/acp.0115","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Posttraumatic stress disorder (PTSD) is not recognized as an indication for electroconvulsive therapy (ECT). However, research indicates promise for this treatment modality. To elucidate the effects of ECT for treating PTSD, prospective research is needed. The first step in assessing the feasibility of such research is to determine if many patients being treated with ECT have comorbid PTSD. This study examined the PTSD comorbidity rates and compared demographic data among patients with major depressive disorder (MDD) who were treated with ECT vs patients with MDD who were not treated with ECT.

Methods: Data from patients with MDD were obtained from the Nationwide Inpatient Sample.

Results: Approximately 10% of patients undergoing ECT for MDD also had PTSD. The difference in comorbidity of PTSD in those treated with ECT vs those not treated with ECT was approximately 1%.

Conclusions: Prospective naturalistic studies that examine the response of PTSD to ECT are feasible because a sizable number of patients with PTSD are receiving ECT.

查看原文本刊更多论文

接受ECT治疗的重度抑郁症患者的创伤后应激障碍合并症。

背景：创伤后应激障碍（PTSD）不被认为是电休克治疗（ECT）的指征。然而，研究表明这种治疗方式很有前景。为了阐明ECT治疗创伤后应激障碍的效果，需要进行前瞻性研究。评估此类研究可行性的第一步是确定是否有许多接受ECT治疗的患者患有创伤后应激障碍。本研究检查了接受ECT治疗的重度抑郁症患者与未接受ECT治疗患者的PTSD合并症发生率，并比较了人口统计学数据。方法：从全国住院患者样本中获得MDD患者的数据。结果：约10%接受ECT治疗MDD的患者也患有PTSD。接受ECT治疗的患者与未接受ECT治疗患者的PTSD合并症差异约为1%。结论：研究PTSD对ECT反应的前瞻性自然主义研究是可行的，因为相当多的PTSD患者正在接受ECT治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Clinical Psychiatry PSYCHIATRY-

CiteScore

1.80

自引率

7.70%

发文量

审稿时长

>12 weeks

期刊介绍： The ANNALS publishes up-to-date information regarding the diagnosis and /or treatment of persons with mental disorders. Preferred manuscripts are those that report the results of controlled clinical trials, timely and thorough evidence-based reviews, letters to the editor, and case reports that present new appraisals of pertinent clinical topics.